1.Biological effects of fucoidan isolated from Fucus vesiculosus on thrombosis and vascular cells.
Kyu Won KWAK ; Kil Sang CHO ; Ok Jin HAHN ; Kwang Hyung LEE ; Boo Yong LEE ; Jung Jae KO ; Kwang Hoe CHUNG
Korean Journal of Hematology 2010;45(1):51-57
BACKGROUND: Fucoidan is a highly sulfated glycosaminoglycan, which has a molecular structure similar to that of heparin. The antithrombotic effects of fucoidan in vitro have been widely reported, but its antithrombotic effects in vivo as well as its other biological properties in vitro have not been well investigated. METHODS: This study investigated the effects and mechanism of fucoidan from Fucus vesiculosus on thrombosis both in vitro and in vivo. A ferric chloride-induced mouse carotid artery thrombosis model was used to determine the antithrombotic effects of fucoidan in vivo. Additionally, changes in the levels of proinflammatory cytokines and chemokines were examined in vascular cells treated with fucoidan. RESULTS: In vivo studies employing a ferric chloride-induced mouse carotid artery thrombosis model indicated that fucoidan had a stronger antithrombotic activity than heparin. Further, vascular cells treated with fucoidan demonstrated a decrease in proinflammatory cytokine and chemokine production as well as inhibition of proliferation. CONCLUSION: The major findings of this study showed that fucoidan has a stronger antithrombotic effect than heparin in vivo and that fucoidan has an inhibitory effect on proinflammatory cytokine production and proliferation of vascular cells.
Animals
;
Carotid Artery Thrombosis
;
Chemokines
;
Cytokines
;
Fucus
;
Glycosaminoglycans
;
Heparin
;
Mice
;
Molecular Structure
;
Polysaccharides
;
Thrombosis
2.Evaluation of adjuvant effects of fucoidan for improving vaccine efficacy.
Journal of Veterinary Science 2015;16(2):145-150
Fucoidan is a sulfated polysaccharide derived from brown seaweed, including Fucus vesiculosus. This compound is known to have immunostimulatory effects on various types of immune cells including macrophages and dendritic cells. A recent study described the application of fucoidan as a vaccine adjuvant. Vaccination is regarded as the most efficient prophylactic method for preventing harmful or epidemic diseases. To increase vaccine efficacy, effective adjuvants are needed. In the present study, we determined whether fucoidan can function as an adjuvant using vaccine antigens. Flow cytometric analysis revealed that fucoidan increases the expression of the activation markers major histocompatibility complex class II, cluster of differentiation (CD)25, and CD69 in spleen cells. In combination with Bordetella bronchiseptica antigen, fucoidan increased the viability and tumor necrosis factor-alpha production of spleen cells. Furthermore, fucoidan increased the in vivo production of antigen-specific antibodies in mice inoculated with Mycoplasma hyopneumoniae antigen. Overall, this study has provided valuable information about the use of fucoidan as a vaccine adjuvant.
Adjuvants, Immunologic/pharmacology
;
Animals
;
Antigens, Bacterial/*immunology
;
Bacterial Vaccines/administration & dosage/*immunology
;
Biomarkers/metabolism
;
Bordetella bronchiseptica/*immunology
;
Cells, Cultured
;
Cytokines/*metabolism
;
Female
;
Flow Cytometry
;
Fucus/*chemistry
;
Gene Expression Regulation/drug effects
;
Mice
;
Mice, Inbred BALB C
;
Mycoplasma hyopneumoniae/*immunology
;
Polysaccharides/*pharmacology
;
Spleen/metabolism
3.Fucoidan induces G1 phase arrest and apoptosis through caspases-dependent pathway and ROS induction in human breast cancer MCF-7 cells.
Amal M BANAFA ; Sadia ROSHAN ; Yun-Yi LIU ; Hui-Jie CHEN ; Ming-Jie CHEN ; Guang-Xiao YANG ; Guang-Yuan HE
Journal of Huazhong University of Science and Technology (Medical Sciences) 2013;33(5):717-724
Fucoidan is an active component of seaweed, which inhibits proliferation and induces apoptosis of several tumor cells while the detailed mechanisms underlying this process are still not clear. In this study, the effect of Fucoidan on the proliferation and apoptosis of human breast cancer MCF-7 cells and the molecular mechanism of Fucoidan action were investigated. Viable cell number of MCF-7 cells was decreased by Fucoidan treatment in a dose-dependent manner as measured by MTT assay. Fucoidan treatment resulted in G1 phase arrest of MCF-7 cells as revealed by flow cytometry, which was associated with the decrease in the gene expression of cyclin D1 and CDK-4. Annexin V/PI staining results showed that the number of apoptotic cells was associated with regulation of cytochrome C, caspase-8, Bax and Bcl-2 at transcriptional and translational levels. Both morphologic observation and Hoechst 33258 assay results confirmed the pro-apoptotic effect of Fucoidan. Meanwhile, the ROS production was also increased by Fucoidan treatment, which suggested that Fucoidan induced oxidative damage in MCF-7 cells. The results of present study demonstrated that Fucoidan could induce G1 phase arrest and apoptosis in MCF-7 cells through regulating the cell cycle and apoptosis-related genes or proteins expression, and ROS generation is also involved in these processes.
Antineoplastic Agents
;
chemistry
;
pharmacology
;
Apoptosis
;
drug effects
;
genetics
;
Blotting, Western
;
Breast Neoplasms
;
genetics
;
metabolism
;
pathology
;
Caspase 8
;
genetics
;
metabolism
;
Caspases
;
genetics
;
metabolism
;
Cell Proliferation
;
drug effects
;
Cell Size
;
drug effects
;
Cyclin D1
;
genetics
;
metabolism
;
Cyclin-Dependent Kinase 4
;
genetics
;
metabolism
;
Cytochromes c
;
genetics
;
metabolism
;
Dose-Response Relationship, Drug
;
Fucus
;
chemistry
;
G1 Phase Cell Cycle Checkpoints
;
drug effects
;
genetics
;
Gene Expression Regulation, Neoplastic
;
drug effects
;
Humans
;
MCF-7 Cells
;
Microscopy, Fluorescence
;
Molecular Structure
;
Polysaccharides
;
chemistry
;
pharmacology
;
Proto-Oncogene Proteins c-bcl-2
;
genetics
;
metabolism
;
Reactive Oxygen Species
;
metabolism
;
Reverse Transcriptase Polymerase Chain Reaction
;
Signal Transduction
;
drug effects
;
bcl-2-Associated X Protein
;
genetics
;
metabolism